Pharmacokinetics of ciprofloxacin in liver cirrhosis.

Chemotherapy

Abteilung für Innere Medizin mit Schwerpunkt Infektionskrankheiten, Klinikum Rudolf Virchow, Standort Charlottenburg, Deutschland.

Published: April 1991

The pharmacokinetics of ciprofloxacin were evaluated in 11 patients (3 patients with impaired renal function) with advanced liver cirrhosis after a single oral dose of 500 mg. Mean serum peaks were 2.80 +/- 1.00 mg/l in 64 +/- 37 min after intake in patients with normal renal function. Elimination was reduced in comparison with healthy volunteers: t1/2 beta 510 +/- 158 min with a total area under the curve of 18.2 +/- 10.3 mg x h/l. Mean recovery of the parent compound from urine was 38 +/- 9% of the dose. In 3 patients with cirrhosis plus poor renal function, elimination was markedly reduced. In patients under 60 years with good renal function, the standard does not require a reduction.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000238793DOI Listing

Publication Analysis

Top Keywords

renal function
16
pharmacokinetics ciprofloxacin
8
liver cirrhosis
8
function elimination
8
patients
5
+/-
5
ciprofloxacin liver
4
cirrhosis pharmacokinetics
4
ciprofloxacin evaluated
4
evaluated patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!